PHARMAROTH LABS ............ !!

buran und MfG

Datum Erster Hoch Tief Schluss     Stücke Volumen
  31.07.14     0,014     0,014§0,014 0,014 $ 18.964 266

GrB

  14.07.14     0,011     0,011§0,011 0,011 $ 26.000 286
  11.07.14    0,0101    0,0101§0,0099 0,01 $ 520.000 5.208
  09.07.14    0,0119    0,0119§0,0115 0,0115 $ 110.000 1.269
  08.07.14    0,0119    0,0119§0,0119 0,0119 $ 80.000 952
  07.07.14    0,0106    0,0119§0,01 0,0119 $ 652.500 6.823
  03.07.14     0,012     0,012§0,012 0,012 $ 45.300 544
  02.07.14    0,0115    0,0115§0,0115 0,0115 $ 100.000 1.150

GrB

Zeit     Kurs Stück
  15:30:01§0,0131 $ 10.000
_____________________
GRATULATION§

For further information, please contact us at (855) 543-4900 (toll-free) or fill out the contact form below.www.singpost.com/corporate-information/history.html

is selective and may not be complete or up-to-date. No representation, undertaking or warranty is or will be made, and no responsibility or liability is or will be accepted by Fero Industries, Inc. or any of its directors, officers, employees or agents as to or in relation to the use of any contents of this website or the accuracy or completeness of this website. Any liability whatsoever for any loss howsoever arising from or in connection with the reliance upon the contents or any part of this website is hereby expressly disclaimed.www.singpost.com/corporate-information/history.html

within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995.www.singpost.com/corporate-information/history.html

other than statements of historical fact are "forward-looking statements" that are based on current expectations and assumptions. These expectations and assumptions are subject to risks and uncertainty, which could affect Fero Industries, Inc.’s future. Forward-looking statements involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by the statements, including, but not limited to, the following: the ability of Fero Industries, Inc. to provide for its obligations, to provide working capital needs from operating revenues, to obtain additional financing needed for any future acquisitions, to meet competitive challenges and technological changes, and other risks. Fero Industries, Inc. undertakes no duty to update any forward-looking statement(s) and/or to confirm the statement(s) to actual results or changes in Fero Industries, Inc.’s expectations.www.singpost.com/corporate-information/history.html

LEGAL DISCLAIMER

CAUTIONARY DISCLOSURE ABOUT FORWARD-LOOKING STATEMENTSwww.singpost.com/corporate-information/history.html

The Resources section provides additional information and links to scientific articles, newsworthy stories and market trends on a wide range of topics related to Fero Industries, Inc., Type 2 diabetes, and Sucanon®.www.singpost.com/corporate-information/history.html

www.singpost.com/corporate-information/history.html GrB

Fero Industries, Inc. is publicly traded company fully reporting with the U.S. Securities and Exchange Commission.

U.S Securities and Exchange Commission:
www.sec.gov/cgi-bin/...01409475&owner=exclude&count=40
www.singpost.com/corporate-information/history.html

Fero Industries, Inc. is an emerging nutraceutical company focused on the prevention and treatment of a major threat facing healthcare - diabetes.
.................................................................­.................................................................­.......

The Company holds the intellectual property and exclusive world-wide rights to the production, marketing and distribution of Sucanon®, a clinically-tested herbal-based nutraceutical treatment for Type-2 diabetes. Fero intends to increase awareness, acceptance, and distribution of Sucanon® globally.www.singpost.com/corporate-information/history.html

Fero Industries, Inc. is a publicly traded company focused on diabetes prevention and treatments (OTCBB: FROI). The Company holds the intellectual property and other exclusive world-wide rights related to the production, marketing, and distribution of Sucanon®, a treatment for Type II diabetes.

Sucanon® is a member of a class of diabetic medications called insulin sensitizers. Insulin sensitizers lower blood sugar by increasing the muscle, fat and liver’s sensitivity to insulin. Insulin sensitizers are blood sugar normalizing or euglycemic drugs that help return the blood sugar to the normal range without the risk of low blood sugars.

Sucanon® has undergone clinical trials in China and Brazil. Sucanon® is approved and is sold as an Over-The-Counter ("OTC") treatment for Type II diabetes in Mexico and as an prescription pharmaceutical in Peru.  An application for United States FDA approval of Sucanon® has not been made.

Type II diabetics in the United States can may buy Sucanon® for their own use and have it delivered to them from Mexico under the U.S. FDA’s “personal importation��?guidelines.  A similar program exists for Type II diabetics in Canada who wish to buy Sucanon® for their own use.  The Company will consider applying for FDA approval in the near future.

Download the latest Fero Industries Corporate Profilewww.singpost.com/corporate-information/history.html

Datum Erster Hoch Tief Schluss     Stücke Volumen
  11.08.14    0,0101    0,0101§0,0101 0,0101 $ 1.750 18

GrB

buran: nur ein börsenboard geführt von www.bundesbank.de 21:18 #1
achte er einfach auf die links
Mit freundlichen Grüssen Mario Meierhof 39517 Lüderitz Gartenstrasse 6
mariomeierhof@web.de
Tel.:039361/96548 Atelier Meierhof 039361/51273 Kuhle
gez MARIO alias buran http://www.ariva.de/…/nur-ein-boersenboard-gefuehrt-von-www…

Deutsche Bundesbank - Startseite
Die Deutsche Bundesbank ist die Zentralbank der Bundesrepublik Deutschland. Zentrales Geschäftsfeld ist die Geldpolitik des Eurosystems.
BUNDESBANK.DE
https://www.facebook.com/mario.meierhof

Kosmonova buran

Kosmonova buran

Pivots sind Chartzonen bzw. Wendepunkte einer angegebenen Periode i. d. R. im tagesgleichen Handel. Auch wöchentliche Pivots oder Monatspivots sind denkbar. Händler nutzen diese Zonen beispielsweise zum Einstieg in den Markt oder zur Gewinnmitnahme. Grundsätzlich gilt: Je mehr Händler die Pivots zum Handeln nutzen, desto besser funktionieren sie. Man spricht von einer selbst erfüllenden Prophezeihung. Besonders in sehr aktiv gehandelten Terminmärkten haben diese errechneten Chartmarken mitunter eine hohe Bedeutung. Vergleiche: Pivot-Punkt
http://www.ariva.de/extras/lexikon.m?begriff=Pivots

Datum Erster Hoch Tief Schluss     Stücke Volumen
  09.01.15     0,005     0,005§0,005 0,005 $ 5.200 27

GrB

::::::::::: 0,0072 $ +44,00% +0,0022 $
In Euro: 0,0062 € | Nasdaq OTC Other, 14.01.15 ,GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
  06.02.15     0,007     0,007§0,0068 0,0068 $ 130.900 917

GrB

::::::: 0,0065 $ ,GrB

-53,57%

::::::: 0,0078 $ ,GrB

..yöah
Schrott, only Schrott:::::

22:40 08.05.15


Die US-Börsen reagieren erleichtert auf den Bericht vom US-Arbeitsmarkt. Der Durchhänger im letzten Monat war wohl doch keine Trendwende, sondern nur eine Delle. Dow Jones und Co laufen mit deutlichen Aufschlägen. http://www.ariva.de/news/Arbeitsmarkt-treibt-Wall-Street-an-5362650

-57,14%
..yöah
GRINS ...
::::::::::::::puuuuuuups inne G.-Zelle, gelle ???:::::::::::::::

:::::::::::::::0,0065 $ +8,33% +0,0005 $
In Euro: 0,0058 € | Nasdaq OTC Other, 09.06.15 ,GrB

Datum Erster Hoch Tief Schluss     Stücke Volumen
  26.06.15    0,0051    0,0051§0,005 0,005 $ 72.900 366

GrB

Datum Erster Hoch Tief Schluss Stücke Volumen
  29.01.16     0,008     0,008§0,007 0,008 $ 139.178 1.104

GrB

:::::::: 0,0037 $ 0,00% +0,00 $
In Euro: 0,0033 € | 26.08.16 Nasdaq OTC Other GrB

......iss noch vieeeeeeeeeeeeel Luft nach obbe bis zu die MINUS 100 !!!

COOL !!!!!!!!!!!!!!!!!!!!!

company worldwide. It focuses on producing, marketing, and distributing Sucanon, an herbal-based nutraceutical treatment for type-2 diabetes. The company was formerly known as Fero Industries Inc. and changed its name to PharmaRoth Labs, Inc. in March 2013. PharmaRoth Labs, Inc. was founded in 2000 and is based in Las Vegas, Nevada. finance.yahoo.com/quote/ROTH/profile?p=ROTH

::::::::::::::::::: 0,0029 $ +16,00% +0,0004 $
In Euro: 0,0026 € | 06.06.17 Nasdaq OTC Other ,GrB

2014
July 23, 2014
PharmaRoth Labs, Inc. Announces New Distribution Agreement in China www.pharmaroth.com/pressreleases.asp